Summary
β-thromboglobulin (BTG) and fibrinopeptide A (FpA) were studied in 68 non-insulin dependent diabetic patients (NIDD) aged 32–81 with a mean duration of diabetes of 9±0.8 SEM years and 44 healthy controls, comparable for age and sex. Diabetic patients were subdivided into subsets according to the presence of microvascular disease, macrovascular disease or the absence of these lesions. Patients with microangiopathy (micro- and/or macrovascular disease) had higher HbA (p<0.01), higher blood pressure (p<0.05) than both healthy controls and uncomplicated diabetics. Plasma BTG was higher in diabetic patients than in healthy controls (p<0.02), and was higher in complicated than in non-complicated diabetic subjects. Fpa was higher in complicated than in non-complicated diabetes (p<0.05). No differences were observed between the two subsets of complicated patients. In conclusion, we have shown that increased plasma- and platelet-BTG levels are present in non-insulin dependent diabetic subjects, with normal renal function and that plasma BTG is higher in patients with than in those without vascular disease. Fibrinopeptide A, a sensitive marker ofin vivo fibrin formation, was significantly increased in NIDD with vascular complications.
Similar content being viewed by others
References
Babson H. L., Shapiro P. O., Phillips G. E.: A new assay for cholesterol esters which is not affected by bilirubin — Clin. chim. Acta7, 800–804, 1962.
Betteridge D. J., Zahavi J., Jones N. A. G., Shine B., Kakkar V. V., Galton D. J.: Platelet function in diabetes mellitus in relationship to complications, glycosylated haemaglobin and serum lipoproteins — Europ. J. clin. Invest.11, 273–277, 1981.
Borsey D. Q., Dawes J., Fraser D. M., Prowse C. V., Elton R. A., Clarke B. F.: Plasma beta-thromboglobulin in diabetes mellitus — Diabetologia18, 353–357, 1980.
Brooks A. M. V., Hussein S., Chesterman C. N., Martin J. F., Alford F. P., Penington D. G.: Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy — Thrombos. Haemost.43, 123–127, 1983.
Burnstein M., Scholy K. H. R., Morfin R.: Rapid method for the isolation of lipoproteins from human serum by precipitations with polyanions — J. Lipid Res.11, 583–595, 1970.
Burrows A. W.: Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A. In:Standl E., Mehnert H. (Eds): Pathogenetic concepts of diabetic microangiopathy. Internat. Workshop Garmisch-Grainau 1980. Georg Thieme Verlag, Stuttgart-New York, 1981; p. 22.
Burrows A. W., Chavin S. I., Hockaday T. D. R.: Plasma-thromboglobulin concentrations in diabetes mellitus — Lanceti, 225–237, 1978.
Campbell I. W., Dawes J., Fraser D. M., Pepper D. S., Clarke B. F., Duncan L. J. P., Cash J. D.: Plasma β-thromboglobulin in diabetes mellitus — Diabetes26, 1175–1177, 1977.
Colwell J. A., Sagel J., Crook L., Chambers A., Laimins M.: Correlation of platelet aggregation, plasma factor activity and megathrombocytes in diabetic subjects with and without vascular disease — Metabolism26, 279–285, 1977.
Eggstein M.: Eine neue Bestimmung der Neutralfette in Blutserum und Gewebe — Klin. Wschr.44, 273–277, 1966.
Franchi F., Canciani M. T., Mannucci P. M.: The β-thromboglobulin test — Thrombos. Haemost.44 (2), 107, 1980.
Jones R. L., Peterson C. M.: Haematologic alterations in diabetes mellitus — Amer. J. Med.70, 339–352, 1983.
Kynoch P. A. M., Lehman H.: Rapid estimation (2 1/2 h) of glycosylated haemoglobin for routine purposes — Lancetii, 16, 1977.
Ludlam C. A., Bolton A. E., Moore S., Cash J. D.: New rapid method for diagnosis of deep venous thrombosis — Lancetii, 259–261, 1975.
Ludlam C. A., Cash J. D.: Studies on the liberation of β-thromboglobulin from human plateletsin vitro — Brit. J. Haematol.33, 239–247, 1976.
Ludlam C. A., Moore S., Bolton A. E., Pepper D. S., Cash J. D.: The release of a human platelet specific protein measured by radioimmunoassay — Thrombos. Res.6, 543–548, 1975.
Margonato A., Vicari A. M., Vicedomini G., Petrelli P., Pozza G.: Plasma beta-thromboglobulin in uncomplicated insulin-dependent diabetes at rest and during physical exercise — Acta diabetol. lat.20, 27–32, 1983.
Matthews J. H., O’Connor J. F., Hearnshaw J. R., Wood J. K.: Beta-thromboglobulin and glycosylated haemoglobin in diabetes mellitus — Scand. J. Haematol.23, 421–426, 1979.
Nossel H. L., Kaplan K. L., Spanondis K., Soland T., Butler V. P.: The generation of fibrinopeptide A in clinical blood samples — J. clin. Invest.58, 1136, 1976.
Nossel H. L., Yudelman I., Canfield R. E., Butler V. P., Spanondis K., Wilner G. D., Qureshi G. B.: Measurement of fibrinopeptide A in human blood — J. clin. Invest.54, 43, 1974.
Porta M., Peters A. M., Cousins S. A., Cacliero E., Fitzpatrick M. L., Kohner E. M.: A study of platelet-relevant parameters in patients with diabetic microangiopathy — Diabetologia25, 21–25, 1983.
Preston F. E., Ward J. D., Marcola B. H., Porter N. R., Timperley W. R., O’Malley B. C.: Elevated β-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy — Lanceti, 238–239, 1978.
Rak K., Beck P., Udwardy M., Pfliegler G., Misz M., Boda Z.: Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults — Thrombos. Res.29, 155–162, 1983.
Schernthaner G., Silberbauer K., Sinzinger H., Muller M.: Plasma β-thromboglobulin and glycosylated hemoglobin (HbAi) in type I and type II dabetes mellitus — Thrombos. Haemost.42, 334, 1979.
van Oost B. A., Veldhuyzen B. F. E., van Houwelingen H. C., Timmermans A. P. M., Sixma J. J.: Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease — Thrombos. Haemost.48, 289–293, 1982.
Voisin P. H., Rousselle D., Drovin P., Stoltz J. F.: Beta-thromboglobulin levels in diabetes mellitus: influence of degenerative lesions and glycemic regulation using an artificial pancreas — Thrombos. Res.30, 245–255, 1983.
Author information
Authors and Affiliations
Additional information
This study was supported by the Juvenile Diabetes Foundation Grant N. 184066 and by the National Research Council of Italy,Progetto Finalizzato di Medicina Preventiva e Riabilitativa, Sottoprogetto 4.
Rights and permissions
About this article
Cite this article
Librenti, M.C., D’Angelo, A., Micossi, P. et al. β-thromboglobulin and fibrinopeptide a in diabetes mellitus as markers of vascular damage. Acta diabet. lat 22, 39–45 (1985). https://doi.org/10.1007/BF02591091
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02591091